Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Beckman Coulter progresses on workstation consolidation

This article was originally published in Clinica

Executive Summary

The EU is an important market for Beckman Coulter, and is increasingly seen by the Fullerton, California company as a worldwide launch market. "The European launches started with the Automate 800. Because the system has been such a success, it is now also going to be introduced at the US AACC meeting in San Diego this year," said Beckman Coulter Europe's vice-president, marketing diagnostics, EMEA and India, Marcel van Kasteel. Speaking to Clinica, Mr van Kasteel, who is helping to drive growth in Europe for the $2.53bn turnover (2006) lab systems group, said that the new workstation consolidation system, UniCel DxC 880i, currently in development, will also be unveiled first in Europe. The combination system, comprising a closed tube aliquotter (CTA) - the key element of this new system - the DxC 800 clinical system and the DxI 800 immunoassay system, has been previewed in Europe and will be exhibited at EuroMedLab 2007 in June, in Amsterdam, the Netherlands. The conference and exhibition will also see the global launch of the UniCel DxI 600.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts